Detalles de la búsqueda
1.
Characterization of treatment resistance and viral kinetics in the setting of single- versus dual-active monoclonal antibodies against SARS-CoV-2.
J Infect Dis
; 2024 May 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38716969
2.
Symptom and Viral Rebound in Untreated SARS-CoV-2 Infection.
Ann Intern Med
; 176(3): 348-354, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36802755
3.
Safety and Efficacy of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies Amubarvimab Plus Romlusevimab in Nonhospitalized Patients With COVID-19.
Ann Intern Med
; 176(5): 658-666, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37068272
4.
Pooling Different Placebos as a Control Group in a Randomized Platform Trial: Benefits and Challenges From Experience in the ACTIV-2 COVID-19 Trial.
J Infect Dis
; 228(Suppl 2): S92-S100, 2023 08 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-37650234
5.
Validity and Characterization of Time to Symptom Resolution Outcome Measures in the ACTIV-2/A5401 Outpatient COVID-19 Treatment Trial.
J Infect Dis
; 228(Suppl 2): S83-S91, 2023 08 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-37650237
6.
Variant-Specific Viral Kinetics in Acute COVID-19.
J Infect Dis
; 228(Suppl 2): S136-S143, 2023 08 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-37650233
7.
Immune Status and SARS-CoV-2 Viral Dynamics.
J Infect Dis
; 228(Suppl 2): S111-S116, 2023 08 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-37650232
8.
Statistical Challenges When Analyzing SARS-CoV-2 RNA Measurements Below the Assay Limit of Quantification in COVID-19 Clinical Trials.
J Infect Dis
; 228(Suppl 2): S101-S110, 2023 08 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-37650235
9.
Nasal and Plasma Severe Acute Respiratory Syndrome Coronavirus 2 RNA Levels Are Associated With Timing of Symptom Resolution in the ACTIV-2 Trial of Nonhospitalized Adults With Coronavirus Disease 2019.
Clin Infect Dis
; 76(4): 734-737, 2023 02 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-36210483
10.
Predictors of virologic outcome among people living with HIV who continue a protease inhibitor-based antiretroviral regimen following virologic failure with no or limited resistance.
AIDS Res Ther
; 20(1): 3, 2023 01 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36604746
11.
Novel Criteria for Diagnosing Acute and Early Human Immunodeficiency Virus Infection in a Multinational Study of Early Antiretroviral Therapy Initiation.
Clin Infect Dis
; 73(3): e643-e651, 2021 08 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33382405
12.
Long-term Outcomes in a Large Randomized Trial of HIV-1 Salvage Therapy: 96-Week Results of AIDS Clinical Trials Group A5241 (OPTIONS).
J Infect Dis
; 221(9): 1407-1415, 2020 04 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31135883
13.
Diverse Human Immunodeficiency Virus-1 Drug Resistance Profiles at Screening for ACTG A5288: A Study of People Experiencing Virologic Failure on Second-line Antiretroviral Therapy in Resource-limited Settings.
Clin Infect Dis
; 71(7): e170-e177, 2020 10 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-31724034
14.
Clinical Trial of the Anti-PD-L1 Antibody BMS-936559 in HIV-1 Infected Participants on Suppressive Antiretroviral Therapy.
J Infect Dis
; 215(11): 1725-1733, 2017 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28431010
15.
HIV Salvage Therapy Does Not Require Nucleoside Reverse Transcriptase Inhibitors: A Randomized, Controlled Trial.
Ann Intern Med
; 163(12): 908-17, 2015 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26595748
16.
Structural effects of linkage disequilibrium on the transcriptome.
RNA
; 18(1): 77-87, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22109839
17.
Evolutionary evidence for alternative structure in RNA sequence co-variation.
PLoS Comput Biol
; 9(7): e1003152, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23935473
18.
Discontinuation of tenofovir disoproxil fumarate from initial ART regimens because of renal adverse events: An analysis of data from four multi-country clinical trials.
PLOS Glob Public Health
; 4(1): e0002648, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38175824
19.
Safety, Efficacy, and Pharmacokinetics of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies BMS-986414 (C135-LS) and BMS-986413 (C144-LS) Administered Subcutaneously in Non-Hospitalized Persons with COVID-19 in a Phase 2 Trial.
Pathog Immun
; 9(1): 138-155, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38746756
20.
Impact of antiretroviral therapy during acute or early HIV infection on virologic and immunologic outcomes: results from a multinational clinical trial.
AIDS
; 2024 Mar 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38489580